Menu Menu


/ News
Wednesday, 29th May 2024 | 4,325 veterinary jobs online | 125 people actively seeking work | 5,495 practices registered

Veterinary Industry News

Send us your news
Powerful Electromagnetic Field Therapy in Non-Invasive Canine Treatment via the MAGCELL®

Powerful Electromagnetic Field Therapy in Non-Invasive Canine Treatment via the MAGCELL®

Powerful Electromagnetic Field Therapy In Non-Invasive Canine Treatment Via The MAGCELL®

4 years ago

28th August, 2020 13h14

PhysioPod UK Limited

"Hi Mary, 

On behalf of Rocco, I want to say a big thank you for the kind loan of the Magcell; it really worked a miracle with his leg.

Here’s a little background leading up to the limping episode:

Rocco our 10 year-old-old Jack Russell Terrier bounds everywhere, jumps off the bed, bounds down the stairs and then bounds out through the front door, up the path to the front gate, especially when he hears a noise that he isn’t happy with!

We live opposite a private nursery and in the mornings the sound of little ones crying as they are dropped off can really cause him concern. I think this is a known factor for both dogs and humans; as we feel discomfort and worry and the need to help. In fact research has shown our cortisol levels are shown to rise when both species hear crying.

On the morning in question, a little one had started to cry and so off Rocco went to help (in his bounding manner to the gate). It was shortly afterwards we noticed that he was limping and could not put his right foot to the floor. It was a very sad sight I may add, and he was feeling very sorry for himself.

When this had happened on another occasion, a vet examined him and advised he had pulled a tendon. He was prescribed anti-inflammatories, to be taken twice a day, with rest advised, no jumping up or down, no long walks and definitely no bounding! With this treatment regime, he had seemed better after seven to ten days.

However, this injury seemed much worse than before and we were about to call the vet again when by chance I bumped in to you Mary and you kindly suggested that the Magcell might help, as it had helped Coco your Labradoodle for a limp with great success. We are so glad we did.

Within a few hours after I treated him with the Magcell he was much better and obviously in less pain. Another couple of treatments did the trick and he appeared fully recovered. Limping gone. Back to his normal self. 

We can’t thank you enough and would recommend the Magcell to any pet owner or in fact, to any human with similar issues. 

Thanks again 

Jeff P.

The effects of Magcell in Canine are clinically proved for the following:​

Effect of Pulsed Electromagnetic Field Therapy on Prostate Volume and Vascularity in theTreatment of Benign Prostatic Hyperplasia: A Pilot Study in a Canine Mode


Benign prostatic hyperplasia (BPH) is a result of urogenital aging. Recent studies suggest that an age-related impairment of the blood supply to the lower urinary tract plays a role in the development of BPH and thus may be a contributing factor in the pathogenesis of BPH. The canine prostate is a model for understanding abnormal growth of the human prostate gland. We studied the efficacy of pulsed electromagnetic field therapy (PEMF) in dogs to modify prostate blood flow and evaluated its effect on BPH.


PEMF (5min, twice a day for 3 weeks) was performed on 20 dogs affected by BPH. Prostatic volume, Doppler assessment by ultrasonography, libido, semen quality, testosterone levels, and seminal plasma volume, composition and pH were evaluated before and after treatment.


The 3 weeks of PEMF produced a significant reduction in prostatic volume (average 57%) without any interference with semen quality, testosterone levels or libido. Doppler parameters showed a reduction of peripheral resistances and a progressive reduction throughout the trial of the systolic peak velocity, end-diastolic velocity, mean velocity, mean, and peak gradient of the blood flow in the dorsal branch of the prostatic artery. The pulsatility index and the resistance index did not vary significantly over time.


The efficacy of PEMF on BPH in dogs, with no side effects, suggests the suitability of this treatment in humans and supports the hypothesis that impairment of blood supply to the lower urinary tract may be a causative factor in the development of BPH. (Leoci et al, 2014)

A further study has now been conducted in humans:​

"Therapeutic use of pulsed electromagnetic field therapy reduces prostate volume and lower urinary tract symptoms in benign prostatic hyperplasia" (Tenuta et al, 2020)

The treatment (2 x 5 min. daily) resulted in a significant volume reduction of the prostate after only 28 days of therapy (V1) compared to the start of treatment (V0).

That the therapy effect is sustainable is shown by the fact that even after 4 months (V2) there was a significantly reduced prostate volume compared to the start of treatment (V0).

The survey on quality of life (IPSS questionnaire: urination/quality of life) also showed significantly better results at both points in time (V1 and V2) than V0.

Overall, there was a rapid improvement in symptoms without changes in gonadal hormones or sexual function, with high compliance and without side effects.

Best results were achieved in moderate to severe symptoms (LUTS) and patients without metabolic syndrome (MetS). 



PRICE: £485.00 including vat and delivery in the UK and Ireland.  

Please email [email protected] for an order form which includes contraindications.

Read the diary of a gentleman using the Magcell Microcirc for BPH

Detailed Magcell Information

MAGCELL® is a portable hand device for electrode-free electrotherapy. Magnetic alternating fields are produced over rotation by permanent magnets. A sinusoidal pulsating electromagnetic field (PEMF) is generated over the special magnet arrangement and device function principle. However, with a value of 0,105 tesla field strength it is many times higher than for commercially available magnetic field therapy devices with coils or mats, which generally operate with field strengths of maximum 100 gauss or 0.01 tesla. By contrast MAGCELL®-therapy units produce field strengths, which are generally stronger by factor 10 than these devices.

According to induction law induced time-variable magnetic fields induce electric fields. The physical effects of MAGCELL® derive from the electric fields produced in living cells and tissue based on induction law. Depending on tissue conductivity the field incites an electric current. Considering the specific conductivity for various body tissue and liquids, this electric current can be calculated. Its strength, or more precisely, current density (= current strength per area, A/m²) determines biological effectiveness.

All calculated current densities exceed 10 mA/m² and are thus within the range of effects internationally confirmed and classified as ‘good‘: above the ‘subtle biological effects‘ and within the range of ‘confirmed macro effects‘ (10-100 mA/m²). Induced current densities are much higher again in blood and body fluids. The term ‘electrode-free electrotherapy‘ for MAGCELL® derives from the distinctly strong induced current densities and exceeding of the threshold value of 10 mA/m²: both of which are not found on equipment using coils or mats.

Body fluids (e.g. joint fluid) play a key role in the relevant therapy indications for MAGCELL® devices. The cells in this fluid or adjacent tissue are exposed to the established current densities. MAGCELL® exceeds by far the recognised effective current densities so that treatment is effective even at a tissue depth of 3-5 cm. MAGCELL® also induces above-threshold current densities in the blood, which are crucial for clinical therapy effects, for instance in respect of blood flow stimulation and immunomodulatory processes. The same applies for interstitial liquids, which moreover are found in virtually all organs and tissue. In bones and fatty tissue with low conductivity current densities are well below the effectiveness threshold of 10 mA/m², so a therapeutic effect in this tissue can scarcely be envisaged.

Magcell® References

Funk H.W., Knels L., Augstein A., Marquetant R., Dertinger H.F. (2014): Potent Stimulation of Blood Flow of Volunteers after Local Short-Term Treatment with Low-Frequency Magnetic Fields from a Novel Device. Evidence-Based Complementary and Alternative Medicine 2014. Article ID 543564, 9 pages

Funk R.H.W. (2018): Coupling of pulsed electromagnetic fields (PEMF) therapy to molecular grounds of the cell. Am J Transl Res 10(5):1260-1272.

Geiger G., Mikus E., Dertinger H., Rick O. (2015): Low frequency magnetic field therapy in patients with cytostatic-induced polyneuropathy: A phase II pilot study. Bioelectromagnetics 36(3): 251-254. doi: 10.1002/bem.21897.

Hitrov N.A., Portnov V.V. (2008): MAGCELL® ARTHRO in der Behandlung von Arthrose im Kniegelenk. Die Naturheilkunde 3, 25-27. - English translation (Hitrov N.A., Portnov V.V. (2008): MAGCELL® ARTHRO in the treatment of osteoarthritis of the knee joint. Naturopathy 3, 25-27.)

Leoci R., Aiudi G., Silvestre F., Lissner E., Lacalandra G.M. (2014): Effect of Pulsed Electromagnetic Field Therapy on Prostate Volume and Vascularity in the Treatment of Benign Prostatic Hyperplasia: A Pilot Study in a Canine Model. The Prostate 74: 1132-1141.

Reimschüssel A., Bodenburg P. (2009): Niederfrequente elektromagnetische Felder. Erfolgreich in der Therapie der Myoarthritis des Kiefergelenkes. Die Naturheilkunde 5, 28. - English translation: Reimschüssel A., Bodenburg P. (2009): Low-frequency electromagnetic fields. Successful in the therapy of myoarthritis of the temporomandibular joint. Naturopathy 5, 28.

Rick O., von Hehn U., Mikus E., Dertinger H., Geiger G. (2017): Magnetic Field Therapy in Patients With Cytostatics-Induced Polyneuropathy: A Prospective Randomized Placebo-Controlled Phase-III Study. Bioelectromagnetics 38(2): 85-94:. doi: 10.1002/bem.22005.

Tenuta et al, (2020) Therapeutic use of pulsed electromagnetic field therapy reduces prostate volume and lower urinary tract symptoms in benign prostatic hyperplasia. Andrology. 2020 Feb 23. doi: 10.1111/andr.12775. [Epub ahead of print]

Wuschech H., von Hehn U., Mikus E., Funk R.H. (2015): Effects of PEMF on patients with osteoarthritis: Results of a prospective, placebo-controlled, double-blind study. 

More from PhysioPod UK Limited

You might be interested in...